Atlas Trials

Dose-escalation Study of Single Dose GHB04L1 in Healthy Adults

Clinical trial NCT00741806 · COMPLETED

Trial details

NCT number
NCT00741806
Sponsor
AVIR Green Hills Biotechnology AG
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Influenza
Start date
2008-08-01
Primary completion
2009-12-01
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.